Multiple outlets report that a woman is the first patient in the world to receive a pioneering new cancer therapy. The reports describe the treatment as a new, experimental approach intended to target cancer cells in a way that differs from existing options. While details of the therapy’s mechanism and the specific cancer type are not fully provided in the supplied excerpts, both sources characterize the treatment as a significant milestone and indicate that it is being administered as part of early-stage clinical testing. The patient is described as becoming the first recipient globally, suggesting the therapy is now moving from development into human trials. The coverage frames the event as a step forward in cancer research, with the primary goal of assessing safety and early effectiveness. The reports do not provide consistent additional outcomes or long-term results in the information available here. Overall, the accounts agree on the central point: the therapy is being given for the first time to a patient, and she is the first in the world to receive it.